Brief: GenOway and Merck Strengthen CRISPR/Cas9 Strategic Alliance

genOway SA

07/01/2020 09:19

Jan 7 (Reuters) - GENOWAY  ALGEN.PA :
    * GENOWAY EXTENDS ITS STRATEGIC ALLIANCE WITH MERCK 
    * GENOWAY ACQUIRES ADDITIONAL RIGHTS TO DEVELOP ALL ANIMAL
CELL
MODELS USING THE CRISPR/CAS9 SYSTEM
    * LICENSE PROVIDES GENOWAY WITH NON-EXCLUSIVE RIGHTS TO
COMMERCIALIZE DEVELOPMENT AND USE OF ALL OTHER ANIMAL CELL
MODELS FOR ITS CUSTOMERS' INTERNAL RESEARCH USES AS WELL AS
COMMERCIAL EXPLOITATION

    
 Source text for Eikon:  urn:newsml:reuters.com:*:nPNAXJw5Xa
    
 Further company coverage:  ALGEN.PA  
   


 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10))